OWLT NYSE Week ended 31 Jul 2026

Weekly Investor Report

Owlet Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 5.14 USD
-2.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -29.5% below the Trend Line and sits at 7.5% of its 52-week range. The latest completed week returned -2.1%, after a -10.8% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 26/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.

Setup score 24 out of 100
Latest Close 5.14 USD 31 Jul 2026
1W Return -2.1% latest completed week
4W Return -10.8% short-term follow-through
12W Return -10.5% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.1% Latest completed week; four-week move -10.8%. Indicator stack 32/51 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 26/100 conviction; expected move 28.7%. News sentiment 50/100 70 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -29.5% below the Trend Line and sits at 7.5% of its 52-week range. The latest completed week returned -2.1%, after a -10.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1212-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.8% over four weeks, -10.5% over 12 weeks, and -30.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.1%
4W-10.8%
12W-10.5%
26W-57.4%
52W-30.4%
Active trend streak0 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.19Latest activity-pressure read.
Pressure change-29.4%Four-week change in activity pressure.
Leadership-45.25Latest relative-leadership reading.
RS change-11.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength5/100Blend of value, momentum, and quality. Underlying universe rank 96; rank 1 is best.
Value27/100Relative valuation strength. Underlying universe rank 74; rank 1 is best.
Quality8/100Profitability and accounting quality. Underlying universe rank 93; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-6.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
50.9%
Gross profit retained from each unit of revenue.
Operating margin
-41.0%
Operating profit retained from revenue.
Free-cash-flow margin
-8.1%
Free cash flow generated from revenue.
Return on invested capital
-241.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
26.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-22.8%
Net share repurchases relative to market value.
Shareholder yield
-22.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

OWLT shows mixed options pressure with a 26/100 conviction score, put-call volume ratio of n/a, expected move of 28.7%, and Sharemaestro trend signal inactive.

Conviction26/100
Expected move28.7%
Put/call volume
Pressure9
Speculation0
Volatility96
Trend agreement48
Open options detail
Insider activity1 / 2

1 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 70 relevant articles.

12 positive · 48 neutral · 10 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move28.7%Nearest-chain priced movement where available.
52-week drawdown-69.7%Distance below the 52-week high.
13-week volatility8.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+18.6%Week of 8 May.
Worst week-37.1%Week of 6 Mar.
Latest week-2.1%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains2
Flat weeks0
Modest losses4
Sharp losses12
Recent vol8.5%13-week weekly-return volatility.
Base vol10.8%52-week weekly-return volatility.
Up/down split23/27Count of positive and negative weeks in the 52-week window.
Average skew9.0% / -7.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis21/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.12; No reversal markers Factors11/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 92; Small Cap Core rank 76 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options43/100

OWLT shows mixed options pressure with a 26/100 conviction score, put-call volume ratio of n/a, expected move of 28.7%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 28.7% Sentiment50/100

Weighted news tone is neutral across 70 relevant articles.

Analysts Conflicted on These Healthcare Names: Chemed (CHE), Koninklijke Philips (PHG) and Owlet (OWLT) Insiders1 / 2

1 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20265.14 USD-2.1%7.29 USD6.06 USD0.19-45.25499.6KOff
24 Jul 20265.25 USD-6.2%7.66 USD6.06 USD0.24-43.91535.8KOff
17 Jul 20265.60 USD-8.0%8.00 USD6.06 USD0.36-41.04873.7KOff
10 Jul 20266.09 USD5.7%8.29 USD6.06 USD0.40-37.38834.2KOff
3 Jul 20265.76 USD4.9%8.57 USD6.04 USD0.26-40.50716.1KOff
26 Jun 20265.49 USD9.8%8.85 USD6.04 USD0.15-42.571.3MOff
19 Jun 20265.00 USD7.5%9.10 USD6.03 USD-0.04-49.351.6MOff
12 Jun 20264.65 USD-0.4%9.33 USD6.03 USD-0.30-52.82719.8KOff
5 Jun 20264.67 USD-15.6%9.53 USD6.02 USD-0.44-52.741.8MOff
29 May 20265.53 USD-4.5%9.67 USD6.01 USD-0.61-45.751.2MOff
22 May 20265.79 USD4.3%9.79 USD6.00 USD-0.86-42.54834.1KOff
15 May 20265.55 USD-3.3%9.91 USD5.98 USD-1.06-44.51908.0KOff
8 May 20265.74 USD18.6%10.01 USD5.97 USD-1.18-42.611.1MOff
1 May 20264.84 USD-7.5%10.11 USD5.96 USD-1.26-50.53813.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.